Charles River Laboratories International Inc. presented at the William Blair 45th Annual Growth Stock Conference, where Executive Vice President & Chief Financial Officer Flavia Pease highlighted the company's global scale and market position. With approximately 20,000 employees worldwide, including around 2,500 scientific professionals with advanced degrees, Charles River Laboratories serves more than 2,000 biopharma clients primarily in North America and Europe. The company operates over 130 locations in more than 20 countries and generates about 70% of its revenue from the biopharma industry. The company is recognized as a leader in research models, safety assessment, and microbial solutions, supporting over 80% of FDA-approved novel drugs from 2020 to 2024. You can access the full presentation through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.